van Zyl G

Evaluation of the performance of three biomarker assays for recent HIV infection using a well-characterized HIV-1 subtype C incidence cohort
Gonese E, Kilmarx PH, van Schalkwyk C, Grebe PE, Mutasa K, Ntozini R, Parekh BS, Dobbs T, Pottinger YD, Masciotra S, Owen M, Nachega JB, van Zyl G, Hargrove JW

AIDS Research And Human Retroviruses

(2019)

https://doi.org/10.1089/aid.2019.0033
Assessment of HIV transfusion transmission risk in South Africa: a 10-year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes
Vermeulen M, Lelie N, Coleman C, Sykes N, Jacobs G, Swanevelder R, Busch MP, van Zyl G, Grebe PE, Welte A, Reddy R

Transfusion

(2019)

https://doi.org/10.1111/trf.14959
Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy
Humphrey JH, Hargrove JW, Welte A, Marinda ET, Preiser W, Slabbert H, van Zyl G, Levin J, Moulton LH

Journal of Acquired Immune Deficiency Syndromes

(2010)

https://doi.org/10.1097/qai.0b013e3181b61938